Mapping Isomeric Peptides Derived from Biopharmaceuticals Using High-Resolution Ion Mobility Mass Spectrometry

Anal Chem. 2021 Dec 14;93(49):16379-16384. doi: 10.1021/acs.analchem.1c02834. Epub 2021 Nov 29.

Abstract

The identification and localization of isomeric peptide modifications is a critical requirement of the biopharmaceutical industry. Despite the ability of liquid chromatography-mass spectrometry to identify many of the common post translational modifications, the identification of isobaric or racemized peptides is confounded by modern mass spectrometry-based techniques. Here, we present a novel approach combining liquid chromatography with a high-resolution ion mobility mass spectrometry system to differentiate peptide and peptide fragments based upon their mobility and mass.

MeSH terms

  • Biological Products*
  • Chromatography, Liquid
  • Ion Mobility Spectrometry
  • Mass Spectrometry
  • Peptides

Substances

  • Biological Products
  • Peptides